Is the platelet lowering activity of anagrelide mediated by its major metabolite 2-amino-5,6-dichloro-3,4-dihydroquinazoline (RL603)?
- Exp Hematol. 2002 Jul;30(7):625-6; author reply 626-7. doi: 10.1016/s0301-472x(02)00870-6.
PMID: 12135656
DOI: 10.1016/s0301-472x(02)00870-6
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Drug MetaboliteResearch Areas: Cardiovascular Disease